Vlado Perkovic
The University of Sydney
2 papers in the Anchorcite directory, published between 2017 and 2019, cited 14,454 times in total.
ORCID profileResearch topics
- Diabetes Treatment and Management · 2 papers
- Chronic Kidney Disease and Diabetes · 2 papers
- Heart Failure Treatment and Management · 1 paper
- Acute Kidney Injury Research · 1 paper
Frequent co-authors
- Bruce Charles Neal · 2 papers
- Kenneth W. Mahaffey · 2 papers
- Dick de Zeeuw · 2 papers
- Greg Fulcher · 1 paper
- Ngozi Erondu · 1 paper
- Wayne C. Shaw · 1 paper
- Gordon Law · 1 paper
- Mehul G. Desai · 1 paper
Papers
- Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesNew England Journal of Medicine · 2017 · 8,032 citations
Background Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that reduces glycemia as well as blood pressure, body weight, and albuminuria in people with diabetes. We report the effects of treatment with canagliflozin on cardiovascular, renal, and safety outcomes. Methods The…
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyNew England Journal of Medicine · 2019 · 6,422 citations
BACKGROUND: Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal…
Metadata from OpenAlex (CC0).